Medtronic Reports Q3 Revenue Up 8.7% YoY, Full-Year Adjusted EPS Guidance Below Consensus

Gelonghui February 17 | Medical device manufacturer Medtronic announced its third-quarter results for the fiscal year 2026, with revenue increasing by 8.7% year-over-year to $9 billion, surpassing market expectations by $110 million; adjusted earnings per share were $1.36, exceeding market expectations by $0.02. The company reiterated its organic revenue growth forecast of approximately 5.5% for the fiscal year 2026, with an adjusted earnings per share forecast of $5.62 to $5.66, below the market consensus expectation of $6.12.